Á¤¹ÐÀÇ·á¼¾ÅÍ ¿öÅ©¼ó 2023 – »óµ¿ÀçÁ¶ÇÕ°áÇÌ(HRD)°ú ÀÓ»óÀû¿ë : 2023-09-01±³À°ÀÏÀÚ : 2023-09-01±³À°Àå¼Ò : ¼¿ï´ëÇб³º´¿ø¾î¸°À̺´¿ø ÁöÇÏ1Ãþ CJHALL ±³À°ÁÖÁ¦ : Á¤¹ÐÀÇ·á¼¾ÅÍ ¿öÅ©¼ó 2023 – »óµ¿ÀçÁ¶ÇÕ°áÇÌ(HRD)°ú ÀÓ»óÀû¿ë
ÁÖÃÖ±â°ü : ¼¿ï´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : Á¤¹ÐÀÇ·á¼¾ÅÍ
´ã´çÀÚ : À忹Àº
¿¬¶ôó : 02-2072-4533
À̸ÞÀÏ : 02916@snuh.org
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, ¾È°ú, À̺ñÀÎÈÄ°ú, ºñ´¢ÀÇÇаú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, ±âŸ
Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 01ÀÏ CJHALL 14:10~14:35 Introduction of HRD in Cancer ¹èÁ¤¸ð(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ CJHALL 14:35~15:00 Detection of HRD by clinical targeted sequencing À̼º¿µ(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ CJHALL 15:00~15:25 HRD-directed therapies and development pipelines ÀÌ°æÈÆ(¼¿ï´ëÇб³º´¿ø)
Åä·Ð 09¿ù 01ÀÏ CJHALL 15:25~15:40 Åä·Ð ()
ÈÞ½Ä 09¿ù 01ÀÏ 15:40~15:50 ÈÞ½Ä ()
±³À°½Ã°£ 09¿ù 01ÀÏ CJHALL 15:50~16:15 HRD-guided therapy in Breast Cancer ±è½ÃÇö(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ CJHALL 16:15~16:40 HRD-guided therapy in Prostate and Pancreatic Cancer ¹ÚÀαÙ(¼¿ï¾Æ»êº´¿ø)
±³À°½Ã°£ 09¿ù 01ÀÏ CJHALL 16:40~17:05 HRD-guided therapy in Ovarian Cancer ±è¹Ì°æ(ÀÌ´ë¸ñµ¿º´¿ø)
Åä·Ð 09¿ù 01ÀÏ CJHALL 17:05~17:20 Åä·Ð ()
±âŸ 09¿ù 01ÀÏ 17:15~17:20 Ŭ·Î¡ ()